Usiano Afrika, the innovation revolution
The story of the elimination of thimerosal, a mercury-based preservative, from vaccines in the United States is a striking example of public health vigilance. 1999: A Call to Action In July 1999, US public health agencies, in collaboration with the American Academy of Pediatrics and vaccine manufacturers, issued a call to action.
Lenacapavir, an innovative drug developed by Gilead Sciences and based on research from Wesley Sundquist's laboratory at the University of Utah, could transform the fight against HIV. This injectable treatment offers unprecedented protection, with clinical trials showing efficacy of 96 to 100 % in preventing infection by
Sickle cell anaemia is a recessive hereditary disease affecting between 15-25 % of the population in sub-Saharan Africa. Nigeria and the Democratic Republic of Congo (DRC) are the two countries most affected in Africa, with a carrier prevalence (AS) of around 25 %, or one family in four. The WHO has formulated strategies to
The Nobel Prize for Medicine has been awarded to Katalin Kariko and Drew Weissman, two researchers from the University of Pennsylvania, for their major contribution to the creation of the messenger RNA vaccine. This distinction marks a break with tradition by rewarding contemporary scientists, and underlines the importance of their work in the context of
A team of researchers at the Weizmann Institute in Israel has just achieved an extraordinary scientific feat: the creation of complete models of human embryos without the use of sperm, eggs or a womb. Not only were these embryos created, they also managed to develop without a hitch. This breakthrough marks a real
English (UK) 
Français